- Fluoride May Be Linked to Decreased IQ, Says “Limited Data,” Hard-to-Interpret Study
- First U.S. Death From Bird Flu Reported in Louisiana
- Blood Test May Help Predict How Long Immunity Lasts
- DoxyPEP Lowers Rate of Sexually Transmitted Infections (STIs), Data Suggests
- Multilingual Children with Autism Show Improved Cognitive Function
- Access to Medical Test Results Is Confusing, Anxiety-Provoking
- Caregivers Face Mental, Physical Health Risks
- U.S. Whooping Cough Cases Surge
- Brain Volume, Health Linked to Socioeconomic Status
- Cruise Passenger Dies Amid Norovirus Outbreak That Sickened Dozens
Xtoro Approved for Swimmer’s Ear
Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer’s ear, clinically known as acute otitis externa.
The infection of the outer ear and ear canal, most often caused by ear canal bacteria, has typical symptoms including pain, swelling, redness and discharge, the FDA said in a news release.
The drug’s safety and effectiveness were evaluated in a clinical study of more than 1,200 people, aged 6 months to 85 years. The most common side effects were ear itching and nausea.
Xtoro is produced by Alcon Laboratories, based in Fort Worth, Texas.
More information
The FDA has more about this approval.
Source: HealthDay
Copyright © 2025 HealthDay. All rights reserved.
Related
-
Estrogen May Trigger Binge Drinking, Prelim Study SuggestsA woman’s binge drinking might be related to her...
- December 31, 2024
-
Some Abortion Pill Users Surprised By Pain, Study SaysAbortion pills are safe and effective, but some pain...
- December 20, 2024
-
FDA: Veozah, First Hormone-Free Hot Flash Drug, Issued Black Box WarningThe U.S. Food and Drug Administration (FDA) has issued...
- December 18, 2024
-
Non-heterosexual Women Report Better Sexual Functioning During Midlife
TUESDAY, Dec. 17, 2024 A woman’s sex drive often...
- December 18, 2024
